Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bardelli

Showing results (201-210 of 259) with videos related to

Pageof 26
Sort By:
ESMO Open|September 29, 2020
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trialAndrea Sartore-Bianchi, Sara Lonardi, Cosimo Martino, et al.
Science (New York, N.Y.)|May 25, 2004
Mutational analysis of the tyrosine phosphatome in colorectal cancersZhenghe Wang, Dong Shen, D Williams Parsons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2022
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal CancerErika Durinikova, Nicole M Reilly, Kristi Buzo, et al.
Frontiers in Oncology|July 30, 2019
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With RegorafenibAlessio Amatu, Marta Schirripa, Federica Tosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2010
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancerSherene Loi, Benjamin Haibe-Kains, Samira Majjaj, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 11, 2023
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activityFrancesca Bersani, Francesca Picca, Deborah Morena, et al.
Nature Reviews. Cancer|September 2, 2024
Cancer drug-tolerant persister cells: from biological questions to clinical opportunitiesMariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Science (New York, N.Y.)|November 9, 2019
Adaptive mutability of colorectal cancers in response to targeted therapiesMariangela Russo, Giovanni Crisafulli, Alberto Sogari, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Beatriz Bellosillo, Giulia Siravegna, et al.
Pageof 26

Showing results (201-210 of 259) with videos related to

Sort By:
Pageof 26
ESMO Open|September 29, 2020
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trialAndrea Sartore-Bianchi, Sara Lonardi, Cosimo Martino, et al.
Science (New York, N.Y.)|May 25, 2004
Mutational analysis of the tyrosine phosphatome in colorectal cancersZhenghe Wang, Dong Shen, D Williams Parsons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2022
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal CancerErika Durinikova, Nicole M Reilly, Kristi Buzo, et al.
Frontiers in Oncology|July 30, 2019
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With RegorafenibAlessio Amatu, Marta Schirripa, Federica Tosi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2010
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancerSherene Loi, Benjamin Haibe-Kains, Samira Majjaj, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 11, 2023
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activityFrancesca Bersani, Francesca Picca, Deborah Morena, et al.
Nature Reviews. Cancer|September 2, 2024
Cancer drug-tolerant persister cells: from biological questions to clinical opportunitiesMariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Science (New York, N.Y.)|November 9, 2019
Adaptive mutability of colorectal cancers in response to targeted therapiesMariangela Russo, Giovanni Crisafulli, Alberto Sogari, et al.
British Journal of Cancer|June 28, 2017
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancerDaniele Oddo, Giulia Siravegna, Annunziata Gloghini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Beatriz Bellosillo, Giulia Siravegna, et al.
Pageof 26